Skip to product information
1 of 1

MULTI SCIENCES

Mouse TRANCE/TNFSF11/RANKL Antibody ELISA Kit

Mouse TRANCE/TNFSF11/RANKL Antibody ELISA Kit

SKU:EK2208

Regular price Send Inquiry
Regular price Sale price Send Inquiry
Sale Sold out
View full details

Product Details

Mouse TRANCE/TNFSF11/RANKL Antibody ELISA Kit

Brand MultiSciences
CatNum 70-EK2208
Product Name Mouse TRANCE/TNFSF11/RANKL ELISA Kit
Customs Name Mouse TRANCE/TNFSF11/RANKL ELISA Kit
Application ELISA
Reactivity Mouse
Assay Type Sandwich ELISA
Suitable Sample Type serum, plasma, cell culture supernates
Format 96-well strip plate
Storage 4℃ (unopened) standard stored at -20℃, others stored at 4℃ (opened)
Shipping Condition 4℃
Sample Volume 20 μl
Sensitivity 0.74 pg/ml
Standard Curve Range 31.25 - 2000 pg/ml
Spike Recovery Range 85 % - 118 %
Mean Spike Recovery 0.94
CV of Intra plate 2.9 % - 7.9 %
CV of Inter plate 3.1 % - 5.4 %
Components 96-well polystyrene microplate coated with a monoclonal antibody against IL-22
Mouse IL-22 Standard, lyophilized
IL-22 Detect Antibody
Standard Diluent
Streptavidin-HRP
Assay Buffer (10×)
Substrate (TMB)
Stop Solution
washing Buffer (20×)
Plate Covers
Describtion This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of mouse TRANCE. The Mouse TRANCE/TNFSF11/RANKL ELISA is for research use only. Not for diagnostic or therapeutic procedures.
TNF-related activation-induced cytokine (TRANCE), also known as tumor necrosis factor ligand superfamily member 11 (TNFSF11), receptor activator of nuclear factor kappa-B ligand (RANKL), is a member of the TNF superfamily. Cells known to express TRANCE include osteoblasts, CD4+ and CD8+ T cells, megakaryocytes, bronchial and intestinal epithelium and so on.
TRANCE appears to play a central role in both immune response and bone morphogenesis. During bone development and remodeling, TRANCE expression by osteoblasts in conjunction with M-CSF induces osteoclast formation and activation, resulting in bone resorption. This allows for subsequent bone deposition and remodeling. TRANCE also plays a role in pathological osteoporosis. Its inappropriate expression by activated lymphocytes and osteoblasts results in excessive joint and bone resorption vs. deposition. Overproduction of TRANCE is implicated in a variety of degenerative bone diseases, such as rheumatoid arthritis and psoriatic arthritis.